Table 3 Primary outcomes
Characteristic | rFSH | hMG-HP | p-value* | All Patients |
|---|---|---|---|---|
Mean (SD) total dose of gonadotrophin per IVF cycle (IU) (All patients) | 2072.53 (768.73) | 2540.14 (883.08) | <0.01 | 2194.13 (825.9) |
(≤35 years) | 1974.90 (726.77) | 2418.56 (834.46) | <0.01 | 2085.84 (779.18) |
(≥36 years) | 2280.41 (813.09) | 2761.60 (925.33) | <0.01 | 2415.36 (873.21) |
Mean (SD) total days of gonadotrophin treatment per IVF cycle (All patients) | 11.41 (2.24) | 11.65 (2.42) | <0.01 | 11.47 (2.29) |
(≤35 years) | 11.41 (2.28) | 11.65 (2.48) | <0.01 | 11.47 (2.33) |
(≥36 years) | 11.41 (2.16) | 11.65 (2.31) | <0.01 | 11.48 (2.21) |
Mean (SD) starting dose of gonadotrophin (IU) (All patients) | 176.38 (50.01) | 206.16 (55.64) | <0.01 | 184.12 (53.16) |
(≤35 years) | 167.97 (46.65) | 195.94 (53.48) | <0.01 | 174.97 (49.94) |
(≥36 years) | 194.26 (52.18) | 224.76 (54.67) | <0.01 | 202.82 (54.63) |
Median starting dose of gonadotrophin (IU) (All patients) | 150 | 225 | <0.01 | 150 |
(≤35 years) | 150 | 225 | <0.01 | 150 |
(≥36 years) | 187.5 | 225 | <0.01 | 225 |